IREN Ltd Stock Surges 135 After Raising Annual Recurring Revenue Outlook to 44 Billion WLK Q1 2026 Earnings Significant EPS Miss Highlights Challenging Market Conditions Sarepta Therapeutics Maps 2026 Priorities from Strong Cash Position